Free shipping on all orders over $ 500

 About 1 result found for searched term "1446090-79-4" (0.118 seconds)

Cat.No.  Name Target
M10475 Lifirafenib (BGB-283) Raf
Beigene-283
Lifirafenib (BGB-283) is a novel potent and selective RAF Kinase and EGFR inhibitor with IC50 values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.